ARTICLE
7 February 2022

COVID-19 Key EU Developments, Policy & Regulatory Update No. 73

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular update (no. 73 | 17 January 2022) covers key regulatory EU developments related to the evolving COVID-19 situation
European Union Coronavirus (COVID-19)
Kaarli H. Eichhorn’s articles from Jones Day are most popular:
  • with Inhouse Counsel

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • Commission publishes Competition Policy – 2021 at a glance
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Investment Bank releases Investment Report 2021/2022 Medicines and Medical Devices
  • EMA recommendations to update product information on COVID-19 Vaccines Janssen and Vaxzevria
  • EMA launches initiative on Accelerating Clinical Trials in the EU
  • EMA announces regulators discussion on global regulatory response to COVID-19 Omicron variant
  • EMA publishes findings on continuous monitoring of data on effectiveness of vaccines against COVID-19
  • Commission adopts the Implementing Regulation on the rules and procedures for cooperation of Member States in safety assessment of clinical trials

Cybersecurity, Privacy & Data Protection

  • European Data Protection Supervisor issues decision on complaint against the European Parliament on data protection obligations regarding its COVID testing website

Download >> COVID19 KEY EU DEVELOPMENTS No 73.pdf

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More